These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28038414)

  • 41. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
    Narvekar M; Xue HY; Wong HL
    Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
    Sahana DK; Mittal G; Bhardwaj V; Kumar MN
    J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
    Pandita D; Kumar S; Lather V
    Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
    Zhou YZ; Alany RG; Chuang V; Wen J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation of stabilizer-free, nontoxic PLGA and elastin-PLGA nanoparticle delivery systems.
    Stromberg ZR; Lisa Phipps M; Magurudeniya HD; Pedersen CA; Rajale T; Sheehan CJ; Courtney SJ; Bradfute SB; Hraber P; Rush MN; Kubicek-Sutherland JZ; Martinez JS
    Int J Pharm; 2021 Mar; 597():120340. PubMed ID: 33545284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents delivery.
    Zhang L; Feng Q; Wang J; Sun J; Shi X; Jiang X
    Angew Chem Int Ed Engl; 2015 Mar; 54(13):3952-6. PubMed ID: 25704675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.
    Liu J; Zhang SM; Chen PP; Cheng L; Zhou W; Tang WX; Chen ZW; Ke CM
    J Mater Sci Mater Med; 2007 Nov; 18(11):2205-10. PubMed ID: 17668296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone Regeneration from PLGA Micro-Nanoparticles.
    Ortega-Oller I; Padial-Molina M; Galindo-Moreno P; O'Valle F; Jódar-Reyes AB; Peula-García JM
    Biomed Res Int; 2015; 2015():415289. PubMed ID: 26509156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co-maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery.
    Kerdsakundee N; Li W; Martins JP; Liu Z; Zhang F; Kemell M; Correia A; Ding Y; Airavaara M; Hirvonen J; Wiwattanapatapee R; Santos HA
    Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28714596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
    Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
    Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.
    Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C
    J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking.
    Lee PW; Hsu SH; Tsai JS; Chen FR; Huang PJ; Ke CJ; Liao ZX; Hsiao CW; Lin HJ; Sung HW
    Biomaterials; 2010 Mar; 31(8):2425-34. PubMed ID: 20034662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats.
    Kalaria DR; Sharma G; Beniwal V; Ravi Kumar MN
    Pharm Res; 2009 Mar; 26(3):492-501. PubMed ID: 18998202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
    Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
    Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
    Abrego G; Alvarado HL; Egea MA; Gonzalez-Mira E; Calpena AC; Garcia ML
    J Pharm Sci; 2014 Oct; 103(10):3153-64. PubMed ID: 25091511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.